DocGo Inc. (DCGO)
USD 4.29
(-2.39%)
USD 4.29
(-2.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 15.05 Million USD | -31.04% |
| 2022 | 21.83 Million USD | 108.13% |
| 2021 | 10.48 Million USD | 171.08% |
| 2020 | -14.75 Million USD | 28.92% |
| 2019 | -20.76 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 10.14 Million USD | -36.07% |
| 2024 Q1 | 15.87 Million USD | 35.99% |
| 2023 FY | 15.05 Million USD | -31.04% |
| 2023 Q2 | 1.57 Million USD | 122.83% |
| 2023 Q4 | 11.67 Million USD | 34.06% |
| 2023 Q1 | -6.9 Million USD | -324.43% |
| 2023 Q3 | 8.7 Million USD | 452.55% |
| 2022 Q2 | 4.42 Million USD | -56.12% |
| 2022 Q1 | 10.09 Million USD | -34.68% |
| 2022 FY | 21.83 Million USD | 108.13% |
| 2022 Q4 | 3.07 Million USD | -48.64% |
| 2022 Q3 | 5.98 Million USD | 35.18% |
| 2021 Q1 | -1.87 Million USD | 57.78% |
| 2021 Q4 | 15.45 Million USD | 917.19% |
| 2021 Q3 | 1.51 Million USD | 487.12% |
| 2021 Q2 | 258.75 Thousand USD | 113.81% |
| 2021 FY | 10.48 Million USD | 171.08% |
| 2020 Q2 | -1.71 Million USD | 71.63% |
| 2020 Q1 | -6.03 Million USD | 0.0% |
| 2020 Q4 | -4.43 Million USD | -73.42% |
| 2020 FY | -14.75 Million USD | 28.92% |
| 2020 Q3 | -2.55 Million USD | -49.45% |
| 2019 FY | -20.76 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 97.028% |
| Addus HomeCare Corporation | 90.95 Million USD | 83.448% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -58.758% |
| Amedisys, Inc. | 156.39 Million USD | 90.374% |
| American Oncology Network, Inc. | -49.15 Million USD | 130.628% |
| Astrana Health, Inc. | 84.61 Million USD | 82.207% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -86.509% |
| IMAC Holdings, Inc. | -6.37 Million USD | 336.138% |
| biote Corp. | 28.65 Million USD | 47.465% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 222.358% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 86.643% |
| COMPASS Pathways plc | -136.91 Million USD | 110.996% |
| The Ensign Group, Inc. | 255.36 Million USD | 94.105% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 75.857% |
| InnovAge Holding Corp. | -23.18 Million USD | 164.948% |
| Assure Holdings Corp. | -20.08 Million USD | 174.968% |
| The Joint Corp. | -2.07 Million USD | 826.211% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 107.96% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 195.869% |
| ModivCare Inc. | -139.94 Million USD | 110.758% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -35539.837% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 276.017% |
| Option Care Health, Inc. | 314.59 Million USD | 95.214% |
| P3 Health Partners Inc. | -167.86 Million USD | 108.969% |
| P3 Health Partners Inc. | -167.86 Million USD | 108.969% |
| The Pennant Group, Inc. | 25.16 Million USD | 40.184% |
| Surgery Partners, Inc. | 328 Million USD | 95.41% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 621.367% |
| Talkspace, Inc. | -23.2 Million USD | 164.867% |
| Talkspace, Inc. | -23.2 Million USD | 164.867% |
| The Oncology Institute, Inc. | -77.01 Million USD | 119.547% |
| The Oncology Institute, Inc. | -77.01 Million USD | 119.547% |